Evidence map›Paper›PMID 25425686›Full record

ArticleHaematologica2015

A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.

Patrick Gutschow, Paul J Schmidt, Huiling Han, Vaughn Ostland, Thomas B Bartnikas, Michael A Pettiglio, Carolina Herrera, James S Butler, Elizabeta Nemeth, Tomas Ganz and 2 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. The neogenin-hemojuvelin axis in murine liver is crucial for hepcidin expression.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Patrick GutschowIntrinsic LifeSciences, LLC, La Jolla, CA.
Paul J SchmidtDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA.
Huiling HanIntrinsic LifeSciences, LLC, La Jolla, CA.
Vaughn OstlandIntrinsic LifeSciences, LLC, La Jolla, CA.
Thomas B BartnikasDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI.
Michael A PettiglioDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI.
Carolina HerreraDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI.
James S ButlerAlnylam Pharmaceuticals, Inc., Cambridge, MA.
Elizabeta NemethDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Tomas GanzDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Mark D FlemingDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA.
Mark WestermanIntrinsic LifeSciences, LLC, La Jolla, CA mwesterman@intrinsiclifesciences.com.
Intrinsic LifeSciences (United States) · USBrown University · USHarvard University · USUniversity of California, Los Angeles · USAlnylam Pharmaceuticals (United States) · US

Funding

Regulation of mammalian iron homeostasis by iron and transferrinR00DK084122 · NIDDK · BROWN UNIVERSITY · PI BARTNIKAS, THOMAS BENEDICT · 2013 to 2015
$722k
NIDDK NIH HHS R00 DK084122
6 · The paper itself

Abstract

Mice have been essential for distinguishing the role of hepcidin in iron homeostasis. Currently, investigators monitor levels of murine hepatic hepcidin-1 mRNA as a surrogate marker for the bioactive hepcidin protein itself. Here, we describe and validate a competitive, enzyme-linked immunosorbent assay that quantifies hepcidin-1 in mouse serum and urine. The assay exhibits a biologically relevant lower limit of detection, high precision, and excellent linearity and recovery. We also demonstrate correlation between serum and urine hepcidin-1 values and validate the competitive enzyme-linked immunosorbent assay by analyzing plasma hepcidin response of mice to physiological challenges, including iron deficiency, iron overload, acute blood loss, and inflammation. Furthermore, we analyze multiple murine genetic models of iron dysregulation, including β-thalassemia intermedia (Hbb(th3/+)), hereditary hemochromatosis (Hfe(-/-), Hjv(-/-), and Tfr2(Y245X/Y245X)), hypotransferrinemia (Trf(hpx/hpx)), heterozygous transferrin receptor 1 deficiency (Tfrc(+/-)) and iron refractory iron deficiency anemia (Tmprss6(-/-) and Tmprss6(hem8/hem8)). Novel compound iron metabolism mutants were also phenotypically characterized here for the first time. We demonstrate that serum hepcidin concentrations correlate with liver hepcidin mRNA expression, transferrin saturation and non-heme liver iron. In some circumstances, serum hepcidin-1 more accurately predicts iron parameters than hepcidin mRNA, and distinguishes smaller, statistically significant differences between experimental groups.

Indexed as

Disease Models, AnimalAnemia, Iron-DeficiencyAnimalsbeta-ThalassemiaCells, CulturedEnzyme-Linked Immunosorbent AssayFemaleHemochromatosisHepcidinsHomeostasisHumansInflammationIronIron OverloadLipopolysaccharidesLiverHamp protein, mouseHepcidinsIronLipopolysaccharidesRNA, Messenger

Identifiers

PMID25425686
PMCPMC4803145
OpenAlexW2054380088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.